ArticleScientific reports2025
Computational and bioactivity investigations of flavonoid fraction from Dodonaea viscosa against oxidative stress and inflammation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioactivity-Guided Identification of Metabolites fromMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dodonaea viscosa has long been recognized for its medicinal value, yet a comprehensive understanding of its phytochemical composition and bioactivity remains limited. In this study, a flavonoid-enriched fraction from D. viscosa leaves was investigated by LC-ESI-MS analysis, revealing six phenolic acids and their derivatives alongside sixteen flavonoids, primarily flavones and flavonols. Quantitative analysis confirmed high levels of flavones and flavonols (2518.6 ± 0.13 mg rutin equivalent/100 g extract), while flavanones and dihydroflavonols were present at significantly lower concentrations (401.2 ± 0.11 mg naringenin equivalent/100 g extract). The extract demonstrated potent antioxidant activity, with DPPH scavenging values of 58.36 ± 18, 76.85 ± 13, and 89.75 ± 19%, and ABTS scavenging values of 69.56 ± 0.06, 76.42 ± 0.10, and 84.28 ± 0.07% at concentrations of 10, 50, and 100 μg/mL, respectively. It also exhibited strong dual inhibitory effects against COX-2 (IC₅₀ = 38.21 μg/mL) and 5-LOX (IC₅₀ = 40.72 μg/mL), comparable to indomethacin (IC₅₀ = 33.03 μg/mL) and zileuton (IC₅₀ = 33.41 μg/mL). Mechanistic insights from tandem mass spectrometry and molecular docking further confirmed key interactions responsible for these bioactivities. Collectively, these findings underscore the therapeutic potential of D. viscosa as a natural source of multifunctional bioactive compounds suitable for pharmaceutical and nutraceutical applications. Molecular docking further validated the strong binding affinities of the major flavonoids, with isokaempferide showing particularly stable interactions with COX-2, 5-LOX, and NAD(P)H oxidase. MM-GBSA and hydrogen bond analyses highlighted key residues involved in target inhibition, reinforcing the experimental findings and supporting the potential of D. viscosa flavonoids as promising multifunctional therapeutic leads.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.